This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Exelixis, Inc., Exelixis Patent Company LLC, Luoxin Pharmaceutical (Shanghai) Co., Ltd.. Active years: 2001-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Diego, CA (US) (2001 - 2015)
- Shanghai, CN (2016 - 2023)
Company Filing History:
10 out of 177 
4 out of 13 
4 out of 5 
Years Active: 2001-2023
Areas of Expertise:
Title: The Innovative Journey of Tie-Lin Wang: A Pioneer in Pharmaceutical Patents
Introduction: Tie-Lin Wang is a distinguished inventor based in San Diego, CA, recognized for his significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 24 patents, Wang has established himself as an innovator dedicated to advancing therapeutic solutions through groundbreaking research and development.
Latest Patents: Among his latest patents are two noteworthy inventions. The first, titled "Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors," reveals a novel class of MDM2-p53 inhibitor compounds featuring an imidaxopyrolone structure. This invention specifically discloses compounds represented by formulas (I-1) and (I-2) and their pharmaceutically acceptable salts, offering potential pathways for cancer treatment. The second patent, "Crystal form of estrogen receptor inhibitor and preparation method therefor," introduces a crystal form of an estrogen receptor inhibitor, particularly focusing on crystal form A of a specific compound and its preparation method. This innovation holds promise for developing drugs aimed at treating breast cancer.
Career Highlights: Throughout his career, Tie-Lin Wang has made significant strides in the pharmaceutical industry. He has worked with prominent companies such as Exelixis, Inc. and Exelixis Patent Company LLC, where he contributed to various innovative projects that have advanced the field of drug development.
Collaborations: Wang's journey has also been marked by fruitful collaborations with esteemed colleagues. Notable among them are Richard Martin and Brenton Todd Flatt, with whom he has partnered on several projects, further enriching the landscape of pharmaceutical research and innovation.
Conclusion: Tie-Lin Wang continues to be a prolific inventor, driving advancements in the pharmaceutical sector with his inventive spirit. His latest patents not only showcase his commitment to addressing significant health challenges but also reflect his ongoing dedication to innovation in drug development. As Wang's career unfolds, he remains a pivotal figure within the realm of pharmaceutical inventions, inspiring future generations of inventors and researchers alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile